Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: PharmaPrint

This article was originally published in The Tan Sheet

Executive Summary

PharmaPrint: Files with SEC for secondary offering of approximately 2.3 mil. shares of common stock, the Irvine, Calif.-based company says Dec. 4; proceeds from the offering, estimated to be about $28.4 mil. at an assumed public offering price of $13.75 per share, will be used to fund continued product testing and development, as well as manufacturing of the products PharmaPrint will produce under an agreement with American Home Products ("The Tan Sheet" Oct. 13, In Brief). CIBC Oppenheimer Corp. and Cruttenden Roth Inc. will co-manage the offering. PharmaPrint also signed a $20 mil. three-year contracts with Boulder, Colo.-based Hauser for the latter to manufacture botanical extracts and provide R&D for PharmaPrint's botanical-based dietary supplement and pharmaceutical products...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087854

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel